Yankcom Partnership Novartis Ag Transaction History
Yankcom Partnership
- $182 Billion
- Q1 2025
A detailed history of Yankcom Partnership transactions in Novartis Ag stock. As of the latest transaction made, Yankcom Partnership holds 8,960 shares of NVS stock, worth $1.06 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
8,960
Previous 8,261
8.46%
Holding current value
$1.06 Million
Previous $804 Million
24.25%
% of portfolio
0.55%
Previous 0.43%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.39 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.22 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1.01 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$831 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$797 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $253B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...